117 related articles for article (PubMed ID: 7726141)
21. Expression of cathepsin D and pS2 in imprint smears of breast carcinoma.
Athanassiadou PP; Athanassiades PH; Davaris P; Petrakakou EI; Zerva CI; Kyrkou KA
Cytopathology; 1998 Aug; 9(4):240-7. PubMed ID: 9710694
[TBL] [Abstract][Full Text] [Related]
22. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
[TBL] [Abstract][Full Text] [Related]
23. Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays.
Charpin C; Dales JP; Garcia S; Carpentier S; Djemli A; Andrac L; Lavaut MN; Allasia C; Bonnier P
Clin Cancer Res; 2004 Sep; 10(17):5815-9. PubMed ID: 15355911
[TBL] [Abstract][Full Text] [Related]
24. Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression.
Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Hum Pathol; 2004 Feb; 35(2):176-83. PubMed ID: 14991534
[TBL] [Abstract][Full Text] [Related]
25. [Molecular markers in breast cancer: practical aspects and morphologic evaluation].
Charpin C; Pellissier JF
Bull Acad Natl Med; 1994 Mar; 178(3):475-87; discussion 487-93. PubMed ID: 8076188
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
[TBL] [Abstract][Full Text] [Related]
27. Immunolocalization of the cellular adhesion molecules, intercellular adhesion molecule-1 (ICAM-1) and platelet endothelial cell adhesion molecule (PECAM), in human endometrium throughout the menstrual cycle.
Tawia SA; Beaton LA; Rogers PA
Hum Reprod; 1993 Feb; 8(2):175-81. PubMed ID: 8097204
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.
Foekens JA; van Putten WL; Portengen H; de Koning HY; Thirion B; Alexieva-Figusch J; Klijn JG
J Clin Oncol; 1993 May; 11(5):899-908. PubMed ID: 8487052
[TBL] [Abstract][Full Text] [Related]
29. VLA(3)/integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
Garcia S; Bergeret D; Martini F; Andrac L; Horschowski N; Choux R; Levaut M; Charpin C
Int J Oncol; 1997 Oct; 11(4):849-56. PubMed ID: 21528284
[TBL] [Abstract][Full Text] [Related]
30. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
[TBL] [Abstract][Full Text] [Related]
31. Digital image-analysis of nuclear morphometry, DNA-ploidy and AgNORs in breast-carcinoma cell imprints.
Charpin C; Andrac L; Devictor B; Habib M; Lavaut M; Allasia C; Bonnier P; Piana L
Int J Oncol; 1993 Nov; 3(5):949-56. PubMed ID: 21573458
[TBL] [Abstract][Full Text] [Related]
32. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
33. Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Choux R; Lavaut MN; Allasia C
Am J Clin Pathol; 1998 Apr; 109(4):431-8. PubMed ID: 9535397
[TBL] [Abstract][Full Text] [Related]
34. Immunodetection of HER-2/neu protein in frozen sections evaluated by image analysis: correlation with overall and disease-free survival in breast carcinomas.
Charpin C; Bonnier P; Devictor B; Andrac L; Lavaut MN; Allasia C; Piana L
Anticancer Res; 1993; 13(3):603-12. PubMed ID: 8100412
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody 83D4 immunoreactivity in human tissues: cellular distribution and microcytophotometric analysis of immunoprecipitates on tissue sections.
Charpin C; Pancino G; Osinaga E; Bonnier P; Lavaut MN; Allasia C; Roseto A
Anticancer Res; 1992; 12(1):209-23. PubMed ID: 1567169
[TBL] [Abstract][Full Text] [Related]
36. [The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer].
Saji S; Toi M; Tominaga T
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):368-74. PubMed ID: 8709939
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma.
González-Vela MC; Garijo MF; Fernández F; Buelta L; Val-Bernal JF
Histopathology; 1999 Jan; 34(1):35-42. PubMed ID: 9934582
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal 3C6F9 distribution in human breast carcinomas: image cytometry of immunocytochemical assays.
Charpin C; Dicaire MJ; Barbeau B; Lavaut MN; Andonian C; Devictor B; Allasia C; Bonnier P; Mandeville R
Med Oncol Tumor Pharmacother; 1991; 8(4):243-51. PubMed ID: 1820490
[TBL] [Abstract][Full Text] [Related]
40. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
